WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 心血管疾患患者における三剤併用抗血栓療法 triple antithrombotic therapy in patients with cardiovascular disease
- 2. 非ST上昇型急性冠症候群における抗血小板薬 antiplatelet agents in acute non st elevation acute coronary syndromes
- 3. 周産期心筋症：治療および予後 peripartum cardiomyopathy treatment and prognosis
- 4. 最新の診療アップデート practice changing updates
- 5. 眼の待機手術に対する麻酔 anesthesia for elective eye surgery
English Journal
- Intrapericardial fibrinolysis in purulent pericarditis-case report.
- Dybowska M1, Kazanecka B2, Kuca P3, Burakowski J4, Czajka C5, Grzegorczyk F6, Gralec R7, Tomkowski W8.
- International journal of emergency medicine.Int J Emerg Med.2015 Dec;8(1):36. doi: 10.1186/s12245-015-0087-y. Epub 2015 Oct 7.
- Purulent pericarditis (PP) continues to result in a very serious prognosis and high mortality. The most serious complication of pericarditis is constriction. Intrapericardial administration of fibrinolytic agents, although controversial, can prevent the development of constrictions. We present the c
- PMID 26446031
- Analysis of the influence of antithrombin on microvascular thrombosis: anti-inflammation is crucial for anticoagulation.
- Sorg H1, Hoffmann JO, Hoffmann JN, Vollmar B.
- Intensive care medicine experimental.Intensive Care Med Exp.2015 Dec;3(1):58. doi: 10.1186/s40635-015-0058-x. Epub 2015 Jul 9.
- PURPOSE: Microvascular thrombosis during septic conditions is of essential clinical relevance, but the pathomechanisms are not yet completely understood. The purpose of this study was to study the distinguished differentiation of the interactions of inflammation and coagulation using antithrombin (A
- PMID 26215822
- Antithrombotic Effects of Amaranthus hypochondriacus Proteins in Rats.
- Sabbione AC1,2, Rinaldi G3, Añón MC1,2, Scilingo AA4,5.
- Plant foods for human nutrition (Dordrecht, Netherlands).Plant Foods Hum Nutr.2015 Dec 1. [Epub ahead of print]
- Cardiovascular disease (CVD) is a major cause of disability and premature death throughout the world. Diets with antithrombotic components offer a convenient and effective way of preventing and reducing CVD incidence. The aim of the present work was to assess in vivo and ex vivo effects of Amaranthu
- PMID 26627100
Japanese Journal
- Drug-induced agranulocytosis and repeated stent thrombosis in a patient undergoing stent implantation: case report
- 日本冠疾患学会雑誌 advpub(0), 2016
- NAID 130005156581
- 当院における大腿骨近位部骨折の治療および臨床経過についての考察
- 整形外科と災害外科 65(1), 101-105, 2016
- NAID 130005151249
- Anti-thrombotic effect of rutin isolated from Dendropanax morbifera Leveille(BIOCHEMICAL ENGINEERING)
- Journal of bioscience and bioengineering 120(2), 181-186, 2015-08
- NAID 110009978130
Related Links
- Introduction Since 1999, professional guidelines have recommended the use of the following antithrombotic agents to prevent recurrent ischemic stroke: aspirin (an antiplatelet agent available over-the-counter without a prescription ...
- 1. J Cardiovasc Pharmacol. 1998 Apr;31(4):534-9. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. Atarashi H(1), Endoh Y, Saitoh H, Kishida H, Hayakawa H. Author ...
Related Pictures
![New antithrombotic agents|[mdash]|insights](https://1mg.info/0/4/i/2601.jpg)
★リンクテーブル★
| リンク元 | 「fibrinolytic agent」「thrombolytic drug」「thrombolytic agent」「抗血栓剤」「antithrombotic drug」 |
| 関連記事 | 「agent」「age」「antithrombotic」 |
「fibrinolytic agent」
- 関
- antithrombotic agent、fibrinolytic drug、thrombolytic、thrombolytic agent、thrombolytic drug、thrombolytics
「thrombolytic drug」
- 関
- antithrombotic agent、fibrinolytic agent、fibrinolytic drug、thrombolytic、thrombolytic agent、thrombolytics
「thrombolytic agent」
「抗血栓剤」
「antithrombotic drug」
「agent」
- n.
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
「age」
- n.
- 年齢、歳
- v.
- 加齢する、熟成する
「antithrombotic」
- 抗血栓性の、抗血栓の